Call for Abstract

16th International Conference and Exhibition on Nanomedicine and Pharmaceutical Nanotechnology, will be organized around the theme “Challenges and Innovations in Nanomedicine and Pharmaceutical Nanotechnology”

Nanopharma 2020 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in Nanopharma 2020

Submit your abstract to any of the mentioned tracks.

Register now for the conference by choosing an appropriate package suitable to you.

Nanomedicine is a branch of medicine that applies the knowledge and tools of nanotechnology to the prevention and treatment of disease. Nanomedicine involves the use of nanoscale materials, such as biocompatible nanoparticles and nanorobots for diagnosis, delivery, sensing or actuation purposes in a living organism. Nanotechnology has many definitions but in general it is the use and application of materials with sizes in the nanometre range. Just as a millimetre is one-thousandth of a metre, a nanometre is one-millionth of a millimetre. In more understandable terms, a human hair is approximately 80,000 nanometres in diameter and the growing science and industry of nanotechnology utilises materials below 1000 nanometres. Benefits of working at this very small scale have been seen for many years over such diverse areas as electronics and energy storage to sunscreens and food packaging.

  • Track 1-1NanoparticlesNanoparticles
  • Track 1-2Controlled radical polymerization
  • Track 1-3Nano micro particles
  • Track 1-4Magnetic nanoparticles
  • Track 1-5Silver nanoparticles
  • Track 1-6Gold nanoparticles
  • Track 1-7Nanocomposite microspheres
  • Track 1-8Carbon nanotubes
  • Track 1-9Bio inspired materials and drug delivery
  • Track 1-10Nanobiomechanics and nanomedicine
  • Track 1-11Biosensors and nanobioelectronics
  • Track 1-12Formulation and development

Nanopharmaceuticals offer the ability to detect diseases at much earlier stages and the diagnostic applications could build upon conventional procedures using nanoparticles. Nanopharmaceuticals represent an emerging field where the sizes of the drug particle or a therapeutic delivery system work at the nanoscale. In the pharmaceutical industry, a long standing issue is the difficulty of delivering the appropriate dose of a particular active agent to specific disease site. Nanopharmaceuticals have enormous potential in addressing this failure of traditional therapeutics which offers site-specific targeting of active agents. Such precision targeting via nanopharmaceuticals reduces toxic systemic side effects, resulting in better patient compliance. In today’s world economy, a pharmaceutical industry faces enormous pressure to deliver high-quality products to patients while maintaining profitability. Therefore pharmaceutical companies are applying nanotechnology to enhance or supplement drug target discovery and drug delivery. Nanopharmaceutical reduces the cost of drug discovery, design & development and enhances the drug delivery process. This results in the improved Research & Development success rate which enables faster introduction of new, cost-effective products to the marketplace. 

  • Track 2-1Nanosuspension
  • Track 2-2Nanocarriers
  • Track 2-3Nano engineered drugs
  • Track 2-4Advantages of nanopharmaceuticals

Nanomedicine is simply the application of nanotechnologies in a healthcare setting and the majority of benefits that have already been seen involve the use of nanoparticles to improve the behaviour of drug substances. In today, nanomedicines are used globally to improve the treatments on patients suffering from a range of disorders including ovarian and breast cancer, kidney disease, fungal infections, elevated cholesterol, menopausal symptoms, multiple sclerosis, chronic pain, asthma and emphysema. Nanomedicines that are currently available are overcoming some of the difficulties experienced by normal medical appeal in delivering the benefit from the drug molecules used. In some cases the drugs have very little solubility in water and the human body struggles to absorb enough to treat the condition.  In other cases, the drug molecule is absorbed well but the body removes the drug before it has had long enough to provide benefits.  Drugs may lead to side-effects due to poor delivery at the actual site of disease.  For example, drugs that are targeting cancers must avoid healthy tissues and organs or damage can be caused.  Nanomedicines therefore can play an important role in ensuring enough of the drug enters the body, the entered drug stays in the body for long periods and is targeted specifically to the areas that need treatment.

  • Track 3-1Bio inspired materials and drug delivery
  • Track 3-2Nanomedicine for lung diseases
  • Track 3-3Nanomedicine for blood disorders
  • Track 3-4Nanomedicine for CNS
  • Track 3-5Nanomedicine for gastrointestinal tract (GI) diseases
  • Track 3-6Nanomedicine for cardiovascular diseases
  • Track 3-7Importance of nanomedicine
  • Track 3-8Nano pharmaceutical industry overview
  • Track 3-9Nanocarriers
  • Track 3-10Importance of nanomedicine

Pharmaceutical Nanotechnology deals with emerging new technologies for developing customized solutions for drug delivery systems. The drug delivery system positively impacts the rate of absorption, distribution, metabolism, and excretion of the drug or other related chemical substances in the body. In addition to this the drug delivery system also allows the drug to bind to its target receptor and influence that receptor’s signaling and activity. Pharmaceutical nanotechnology embraces applications of nanoscience to pharmacy as nanomaterials, and as devices like drug delivery, diagnostic, imaging and biosensor.

  • Track 4-1Application of nanotechnology in imaging and diagnostics
  • Track 4-2The biophysics of Nanosystems
  • Track 4-3Fundamentals of physical pharmacy
  • Track 4-4Application of nanotechnology in drug delivery and targeting

With the unprecedented progresses of biomedical nanotechnology during the past few decades, conventional drug delivery systems (DDSs) have been involved into smart DDSs with stimuli-responsive characteristics. Benefiting from the response to specific internal or external triggers, those well-defined nanoplatforms can increase the drug targeting efficacy, in the meantime; reduce side effects/toxicities of payloads, which are key factors for improving patient compliance. In academic field, variety of smart DDSs have been abundantly demonstrated for various intriguing systems, such as stimuli-responsive polymeric nanoparticles, liposomes, metals/metal oxides, and exosomes.

  • Track 5-1Transmucosal drug delivery systems
  • Track 5-2Sonophoresis drug delivery system
  • Track 5-3Lymphoid drug delivery system
  • Track 5-4Insitu drug delivery
  • Track 5-5Micelle drug delivery
  • Track 5-6Emulgel drug delivery
  • Track 5-7Hydrogel in drug delivery

Nanobiotechnologybionanotechnology, and nanobiology are terms that refer to the intersection of nanotechnology and biology. This discipline helps to indicate the merger of biological research with various fields of nanotechnology. Concepts that are enhanced through nanobiology include: nanodevices (such as biological machines), nanoparticles, and nanoscale phenomena that occurs within the discipline of nanotechnology. This technical approach to biology allows scientists to imagine and create systems that can be used for biological research. Biologically inspired nanotechnology uses biological systems as the inspirations for technologies not yet created.

  • Track 6-1Molecular biology
  • Track 6-2Biomedical sciences
  • Track 6-3Latest developments in Nanobiotechnology

Novel Drug delivery system is the advance drug delivery system which improve drug potency, control drug release to give a sustained therapeutic effect, provide greater safety, finally it is to target a drug specifically to a desired tissue.

  • Track 7-1Targeted drug delivery systems
  • Track 7-2Local drug delivery systems
  • Track 7-3Modified drug delivery systems
  • Track 7-4Modified drug delivery systems
  • Track 7-5Ocular drug delivery systems
  • Track 7-6Magnetically induced drug delivery system
  • Track 7-7Transmucosal drug delivery systems
  • Track 7-8Transmucosal drug delivery systems
  • Track 7-9Transdermal drug delivery systems
  • Track 7-10Sustained drug delivery systems
  • Track 7-11Nanoparticulate drug delivery systems

According to the World Health Organization (WHO), there will be 15 million new cases of cancer worldwide in 2020. More than 90% of cancer-related deaths occur by the spread of malignant cells to vital organs, a process called metastasis. Academia, Pharmaceutical and biotechnology companies are making substantial research investments in order to develop specific treatments that can destroy primary and secondary tumors, i.e. those resulting from metastasis to other organs. Nanotechnology in cancer treatments is already a reality providing a wide range of new tools and possibilities, from earlier diagnostics and improved imaging to better, more efficient, and more targeted therapies.

Graphene based materials including pristine graphene sheets, few-layer graphene flakes, and graphene oxide offer a variety of unique, versatile and tunable properties that can be creatively utilised for biomedical applications. Graphene applications in biomedicine are numerous and can be classified into several main areas: transport (delivery) systems, sensors, tissue engineering and biological agents (for example antimicrobials). Potential and promising properties of graphene and 2D materials for developing innovative and revolutionary medical devices that could improve healthcare.

  • Track 9-1Graphene filtration
  • Track 9-2Graphene coatings
  • Track 9-3Graphene medical devices
  • Track 9-4Graphene-based composite materials

Personalized medicine aims to individualize chemotherapeutic interventions on the basis of ex vivo and in vivo information on patient- and disease-specific characteristics. By noninvasively visualizing how well image-guided nanomedicines-that is, submicrometer-sized drug delivery systems containing both drugs and imaging agents within a single formulation, and designed to more specifically deliver drug molecules to pathologic sites-accumulate at the target site, patients likely to respond to nanomedicine-based therapeutic interventions may be preselected. In addition, by longitudinally monitoring how well patients respond to nanomedicine-based therapeutic interventions, drug doses and treatment protocols can be individualized and optimized during follow-up. Furthermore, noninvasive imaging information on the accumulation of nanomedicine formulations in potentially endangered healthy tissues may be used to exclude patients from further treatment. Consequently, combining noninvasive imaging with tumor-targeted drug delivery seems to hold significant potential for personalizing nanomedicine-based chemotherapeutic interventions, to achieve delivery of the right drug to the right location in the right patient at the right time.

  • Track 10-1Nano Medicine in HIV
  • Track 10-2Drug targeting
  • Track 10-3Image-guided drug delivery

Drug delivery is an essential part of pharmaceutical sciences that should be taken into account early in the drug discovery and development process. A drug that cannot be delivered to its site of action is essentially useless. Drug delivery is affected by the physico-chemical properties of the drug and formulation and the interplay of these factors with the transport, binding, and metabolism of the drug in the body. New tools are needed to accurately predict delivery properties of the compounds early during drug discovery, so that the best compounds can be identified for clinical studies. Another class of tools includes the delivery methods that facilitate delivery of hard-to-deliver compounds to the appropriate target sites. Delivery of gene-based drugs (DNA, oligonucleotides, siRNA) and proteins is a major challenge in pharmaceutical science. Nanotechnology can be used to improve drug delivery in these difficult cases. The development and use of nanoparticles in the formulation of these types of drugs is a major focus at CDR, and we welcome productive industrial partnerships to develop these tools for translational use.

  • Track 11-1Drug discovery
  • Track 11-2Drug development
  • Track 11-3Formulation and development
  • Track 11-4Versatile polymers in drug deliver
  • Track 11-5Optimization techniques in drug delivery

Synthesizing nanoparticles for pharmaceutical purposes such as drug preparation can be done in two methods. Bottom up process such as pyrolysis, inert gas condensation, solvothermal reaction, sol-gel fabrication and structured media in which hydrophobic compound such as liposomes are used as bases to mount the drug. Top down process such as attrition / milling in which the drug is chiseled down to form a nanoparticle.

  • Track 12-1Ligands
  • Track 12-2Solid lipid nanoparticles
  • Track 12-3Polymeric nanoparticles
  • Track 12-4Dendrimer nanocarriers
  • Track 12-5Silica materials
  • Track 12-6Nanospheres
  • Track 12-7Nanotubes
  • Track 12-8Nanoshells
  • Track 12-9Nanofiber
  • Track 12-10Nanopolymer
  • Track 12-11Micelles

Tissue engineering is a branch of regenerative medicine, itself a branch of biomedical engineering. Tissue engineering and regenerative medicine are concerned with the replacement or regeneration of cells, tissues (the focus of tissue engineers) or organs to restore normal biological function.

  • Track 13-1Organ fabrication
  • Track 13-2Tissue printing
  • Track 13-3Biologic scaffolds
  • Track 13-4Biomaterials
  • Track 13-5Hydrogels
  • Track 13-6Cell seeded matrices
  • Track 13-7Bioreactor design
  • Track 13-8All aspects of tissue engineering

Biopharmaceutics is defined as the study of factors that influencing rate and amount of drug which reaches the systemic circulation and use of this information to optimize the therapeutic efficacy of the drug products. The process of movement of drug from site of administration to systemic circulation is called as absorption. The concentration of drug in plasma, onset of action, intensity and duration of response depend upon the bioavailability of drug from its dosage form. Bioavailability is defined as the rate and extent (amount) of drug absorption which indicates active effect.

  • Track 14-1Biological drugs
  • Track 14-2Pharmacokinetics of drugs
  • Track 14-3Advances in biological products
  • Track 14-4Applied Biopharmaceutics
  • Track 14-5Efficacy of drug products
  • Track 14-6Generic biological drugs

To date, various nanodrug systems have been developed for different routes of administration, which include dendrimers, nanocrystals, emulsions, liposomes, solid lipid nanoparticles, micelles, and polymeric nanoparticles. Nanodrug systems have been employed to improve the efficacy, safety, physicochemical properties, and pharmacokinetic/pharmacodynamic profile of pharmaceutical substances. In particular, functionalized nanodrug systems can offer enhanced bioavailability of orally taken drugs, prolonged half-life of injected drugs (by reducing immunogenicity), and targeted delivery to specific tissues. Thus, nanodrug systems might lower the frequency of administration while providing maximized pharmacological effects and minimized systemic side effects, possibly leading to better therapeutic compliance and clinical outcomes. In spite of these attractive pharmacokinetic advantages, recent attention has been drawn to the toxic potential of nanodrugs since they often exhibit in vitro and in vivo cytotoxicity, oxidative stress, inflammation, and genotoxicity

  • Track 15-1Nano sized drugs
  • Track 15-2Novel drugs to nano drugs
  • Track 15-3Nanodrugs for cancer therapy
  • Track 15-4Nanodrugs for medical applications
  • Track 15-5Nanodrugs for veterinary therapeutics

Micro and Nanosystems publishes significant original work, topical reviews and guest edited issues ranging from technologies and systems to product innovation and new manufacturing processes with features at the micro and nanoscale. Applications for micro and nanosystems in areas such as health, environment, food, security and consumer goods are covered. The topics to be addressed include Lab-on-a-chip, microfluidics, nano-biotechnology, micro and nanomanufacturing, printed electronics and MEMS. 

  • Track 16-1Imaging
  • Track 16-2Nanodevices
  • Track 16-3Methods of obtention
  • Track 16-4Characterization methods

Nanotechnology has firmly entered the principality of drug delivery. Efficiency of intelligent drug delivery systems is continuously improved with the purpose to maximize therapeutic activity and to minimize undesirable side-effects. The primary goals for research on nano-biotechnologies in drug delivery systems include: More specific drug targeting and delivery, Faster development of new safe medicines, Reduction in toxicity while maintaining therapeutic effects, Greater safety and biocompatibility.

Pharmaceutical conferences  offers presentations by researchers from numerous disciplines through life sciences to engineering, who will addresses a list of topics including gene delivery, protein delivery, peptide delivery, cell delivery, vaccines, transdermal, pulmonary delivery, new materials and other subjects, from varied disciplines while focusing on the theme of drug delivery.

  • Track 17-1Metal Nanoparticles
  • Track 17-2Nanoemulsions
  • Track 17-3Quantum Dots
  • Track 17-4Organic Nanotubes

Pre-clinical advancement enclose the activities that association quiet exposure in the laboratory to beginning of human clinical trials. Preclinical examinations can be planned to recognize a lead confident from a couple of hits, develop the best strategy for new medicine scale-up and select the best detailing, choose the course, repeat, and traverse of presentation; finally help the proposed clinical trial design. Concurrent pre-clinical advancement practices and joins developing clinical courses of action in setting up the new prescription thing, including related documentation to meet stringent FDA Great Assembling Practices and Management system standards.

Nanomedicines have been in the forefront of pharmaceutical research in the last decades, creating new challenges for research community, industry, and regulators. There is a strong demand for the fast development of scientific and technological tools to address unmet medical needs, thus improving human health care and life quality. Tremendous advances in the biomaterials and nanotechnology fields have prompted their use as promising tools to overcome important drawbacks, mostly associated to the non-specific effects of conventional therapeutic approaches. However, the wide range of application of nanomedicines demands a profound knowledge and characterization of these complex products. Their properties need to be extensively understood to avoid unpredicted effects on patients, such as potential immune reactivity. Research policy and alliances have been bringing together scientists, regulators, industry, and, more frequently in recent years, patient representatives and patient advocacy institutions. In order to successfully enhance the development of new technologies, improved strategies for research-based corporate organizations, more integrated research tools dealing with appropriate translational requirements aiming at clinical development, and proactive regulatory policies are essential in the near future.

  • Track 19-1Nanomedicines in the market
  • Track 19-2Regulatory development for “next-generation”of nanomedicine
  • Track 19-3Regulatory perspective on the development of nanomedicines

Pharmacodynamics is the significance that drugs have on the main part; while pharmacokinetics is the study of the way in which drugs move through the body during absorption, distribution, metabolism and excretion. Pharmacokinetics influences decisions over the route of administration. For drugs to products their effects they must interact throughout the body and this can lead upto several behaviors as it depends on the properties of drug, and will be discussed later in this chapter. Pharmacokinetics influences decisions on the route of administration. The processes that occur after drug admin can be broke down into four distinct areas (known as ADME).

  • Track 20-1Absorption Distribution Metabolism Excretion
  • Track 20-2Absorption Distribution Metabolism Excretion
  • Track 20-3Clinical pharmacokinetics
  • Track 20-4Ecotoxicology
  • Track 20-5Multicellular pharmacodynamics
  • Track 20-6Model of pharmacokinetics

Nano Pharmaceutical Market report focuses on the major drivers and restraints for the key players. It also provides granular analysis of the market share, segmentation, revenue forecasts and geographic regions of the market.  The Nano Pharmaceutical Market research report is a professional and in-depth study on the current state of the Nano Pharmaceutical Industry

Pharmaceutical Microbiology deals with the study of microorganisms that are concerned within the manufacturing of prescribed drugs. Alternative aspects of pharmaceutical biological sciences embrace the analysis and the development of anti-infective agents, employment of microorganisms to sight agent and malignant neoplastic disease activity in prospective medication and therefore use of microorganisms within the manufacture of pharmaceutical product like endocrine and human growth hormone.

  • Track 22-1Antimicrobial activity and disinfection
  • Track 22-2Drug safety